Veracyte Inc (NAS:VCYT)
$ 31.64 1.22 (4.01%) Market Cap: 2.43 Bil Enterprise Value: 2.12 Bil PE Ratio: 0 PB Ratio: 2.14 GF Score: 83/100

Veracyte Inc at Jefferies Healthcare Conference Transcript

Jun 06, 2019 / 01:00PM GMT
Release Date Price: $24.88 (+0.93%)
Brandon Couillard
Jefferies LLC, Research Division - Equity Analyst

All right. Thanks, everybody, for joining us. Welcome to the Jefferies 2019 Global Healthcare Conference. I'm Brandon Couillard, senior life science tools and diagnostics analyst here at the firm. Very happy to have Veracyte with us at the conference this year. And here to share an update on the story and all the progress, CEO Bonnie Anderson. Bonnie?

Bonnie H. Anderson
Veracyte, Inc. - Co-Founder, Chairman & CEO

Thank you, Brandon, and I want to start by thanking Jefferies for the opportunity to be here and present at conference. It's great.

Also, we'll begin by reminding everyone of the forward-looking statements that we will likely be making today. And start by giving you a backdrop to our story.

So Veracyte was founded 11 years ago, and today, we are creating a lot of value through innovation. We founded the company with a mission to improve the accuracy of diagnosis of disease, but as I will show you, we have expanded well beyond that today looking at early

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot